SAN CLEMENTE, Calif. , Aug. 29, 2023 /PRNewswire/ -- ICU Medical Inc., a worldwide leader in the development, manufacture and sale of innovative medical devices, today announced that the company has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Duo infusion pump with LifeShield infusion safety software. The Plum Duo pump and LifeShield software will be available to customers in the U.S. in early 2024.
The Plum Duo pump is the newest addition to ICU Medical's portfolio of infusion devices and builds on the precise delivery of the unique cassette technology in the Best in KLAS award-winning Plum 360™. It features a large color touch screen with a highly intuitive user interface and two channels capable of delivering up to four compatible IV medications.
LifeShield infusion safety software is a unified cloud-based software suite that provides advanced new tools for comprehensive drug library management. It fosters collaboration by enhancing clinicians' ability to access, process and quickly share information across an entire enterprise or health system.
"Receiving FDA clearance for the Plum Duo pump and LifeShield software is the first step in realizing ICU Medical's long-term vision of bringing customers best-of-breed devices with a shared platform and user experience," said Dan Woolson, corporate vice president and general manager of ICU Medical Infusion Systems. "We are proud of this milestone and look forward to bringing our next-generation Medfusion™ and CADD™ products to the LifeShield platform, creating the most complete, precise, and technologically advanced infusion systems in the industry for our customers and their patients."
As a large volume infusion delivery platform, the Plum Duo infusion pump with LifeShield infusion safety software are designed to help improve the safety, accuracy and efficiency of IV medication administration, with benefits including:
The introduction of the Plum Duo IV infusion pump with LifeShield infusion safety software is a complementary addition to ICU Medical's comprehensive portfolio of on-market infusion systems, which also features Plum 360 large volume pumps, Medfusion 4000 syringe pumps, CADD-Solis™ pain management pumps, and CADD-Solis VIP™ ambulatory pumps.
Media Contact:
ICU Medical Inc.
Tom McCall
(949) 366-4368
This email address is being protected from spambots. You need JavaScript enabled to view it.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
Last Trade: | US$118.75 |
Daily Change: | 0.03 0.03 |
Daily Volume: | 2,075,370 |
Market Cap: | US$2.890B |
May 07, 2024 March 01, 2024 February 27, 2024 November 06, 2023 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB